XML 60 R51.htm IDEA: XBRL DOCUMENT v3.22.1
Employee Incentive Plans - Restricted and Performance Awards (Details) - USD ($)
$ / shares in Units, $ in Millions
1 Months Ended 3 Months Ended
Mar. 31, 2022
Jan. 31, 2021
Mar. 31, 2022
Mar. 31, 2021
Unvested restricted units        
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]        
Non-vested, beginning of period (in shares)     7,507,471  
Granted (in shares) 193,935   1,761,711  
Vested (in shares)     (1,032,738)  
Forfeited (in shares)     (2,022)  
Non-vested, end of period (in shares) 8,234,422   8,234,422  
Aggregate intrinsic value, end of period $ 79.5   $ 79.5  
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]        
Non-vested, beginning of period (in dollars per share)     $ 5.46  
Granted (in dollars per share)     8.87  
Vested (in dollars per share)     10.35  
Forfeited (in dollars per share)     3.71  
Non-vested, end of period (in dollars per share) $ 5.58   $ 5.58  
Incentive unit award vesting period     3 years  
Units withheld for payroll taxes (in shares)     278,866  
Aggregate intrinsic value of units vested     $ 7.6 $ 3.0
Fair value of units vested $ 1.7   10.7 10.2
Unrecognized compensation cost related to non-vested restricted incentive units $ 24.5   $ 24.5  
Unrecognized compensation costs, weighted average period for recognition     2 years  
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions and Methodology [Abstract]        
Grants in period 193,935   1,761,711  
Performance units        
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]        
Non-vested, beginning of period (in shares)     3,574,827  
Granted (in shares)     598,286  
Vested (in shares)     (708,361)  
Non-vested, end of period (in shares) 3,464,752   3,464,752  
Aggregate intrinsic value, end of period $ 33.4   $ 33.4  
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]        
Non-vested, beginning of period (in dollars per share)     $ 6.40  
Granted (in dollars per share)     11.45  
Vested (in dollars per share)     15.57  
Non-vested, end of period (in dollars per share) $ 5.40   $ 5.40  
Units withheld for payroll taxes (in shares)     273,357  
Aggregate intrinsic value of units vested     $ 5.6 0.6
Fair value of units vested     11.0 $ 4.4
Unrecognized compensation cost related to non-vested restricted incentive units $ 15.5   $ 15.5  
Unrecognized compensation costs, weighted average period for recognition     1 year 10 months 24 days  
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions and Methodology [Abstract]        
Grant-date fair value (in dollars per share) $ 11.90 $ 4.70    
Beginning TSR Price (in dollars per share) $ 8.83 $ 3.71    
Risk-free interest rate 2.15% 0.17%    
Volatility factor 75.00% 71.00%    
Grants in period     598,286  
Performance units | Minimum        
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]        
Percent of units vesting     0.00%  
Performance units | Maximum        
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]        
Percent of units vesting     200.00%  
Performance Shares With Vesting Conditions        
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]        
Granted (in shares)     88,863  
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions and Methodology [Abstract]        
Grant-date fair value (in dollars per share) $ 8.90      
Grants in period     88,863